← Evidence map

ArticleCancer genomics & proteomics

Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma.

Supakan Amontailak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

cites it
Full record →Abstract, authors, funding and every citing paper · PMID 39730185